AMCP Legislative & Regulatory Briefing — October 2024

Now Available: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Report 2024  
On Oct. 10, AMCP unveiled the 2024 edition of Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy report. 

Make a Difference: Help Pass AMCP’s Priority Legislation 
Visit AMCP’s Action Center to call on Congress to enact AMCP’s federal policy priorities: the Access to PDTs Act (S. 723/H.R.1458) and Medicaid VBPs for Patients Act (S. 4204/H.R. 2666). Following the election, Members of Congress will return to Washington D.C. for a final legislative sprint before the next Congress is sworn in on Jan. 3, 2025. 

CA Governor Vetoes Significant PBM Reform Bill
On Sept. 28, California Governor Gavin Newsom (D) vetoed Senate Bill 966, rejecting what was expected to be one of the most significant PBM reform laws to be passed out of state legislatures this year.

Election Update: CBO Releases Analysis on Alternative Approaches to Reducing Drug Prices 
In 2022, the Biden-Harris administration began implementation of the Inflation Reduction Act, which granted Medicare the power to negotiate prices for certain Part D and Part B drugs for the first time. 

CMS Issued Final Guidance for the Second Cycle of the IRA’s Medicare Drug Price Negotiation Program 
On Oct. 2, 2024, the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) issued the Final Guidance for the Second Cycle of the Medicare Drug Price Negotiation Program for Fiscal Year 2027.

Download Full Briefing